Skip to main content

Association of the POLG1 T(−365)C, ANT1 G(−25)A, and PEO1 G(−605)T polymorphisms with diabetic polyneuropathy in patients with Type 1 diabetes mellitus

Molecular Biology volume 43, pages 348–352 (2009)Cite this article

Abstract

This study is dedicated to a search for the association of the polymorphic markers T(−365)C of the POLG1 gene G(−25)A of the ANT1 gene and G(−605)T of the PEO1 gene with diabetic polyneuropathy (DPN) in Type 1 diabetes mellitus (DM1) patients. All patients were ethnic Russian Moscow residents, with DM1 records of no more than 5 years and DPN or DM1 records of more than 10 years but without DPN. We found that the polymorphic marker T(−365)C of POLG1 was associated with DPN in Russian patients with DM1. The carriers of the C allele and the CC genotype had a higher risk of DPN development (OR = 1.62; CI = 1.11–2.38; and OR = 1.76; CI = 0.99–3.13; respectively). In contrast, the T allele carrier status and the TT genotype were associated with a lower DPN risk (OR = 0.62, CI = 0.42–0.90; and OR = 0.61; CI = 0.35–1.07; respectively). We found no association of the polymorphic markers G(−25)A of ANT1 or G(−605)T of PEO1 with DPN in Russian DM1 patients living in Moscow.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Boulton A.J. 2001. Treatments for diabetic neuropathy. Curr. Diab. Rep. 1, 127–132.

    PubMed  Article  CAS  Google Scholar 

  2. IDF Diabetes Atlas. Edition 2003. Available on http://www.eatlas.idf.org/Complications/Prevalence/index

  3. Zotova, E.V., Chistyakov, D.A., Savost’yanov, K.V., Bursa T.R., Galeev I.V., Strokov I.A., Nosikov V.V. 2003. Association of the SOD2 Ala(−9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in diabetes mellitus type 1. Mol. Biol. 37, 345–348.

    Article  CAS  Google Scholar 

  4. Zotova E.V., Savost’yanov K.V., Chistyakov D.A., Bursa T.R., Galeev I.V., Strokov I.A., Nosikov V.V. 2004. Association of polymorphic markers of the antioxidant enzyme genes with diabetic polyneuropathy in type 1 diabetes mellitus. Mol. Biol. 38, 244–249.

    Article  CAS  Google Scholar 

  5. Stevens M.J., Obrosova I., Cao X., et al. 2000. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes. 49, 1006–1015.

    PubMed  Article  CAS  Google Scholar 

  6. Spitsina E.V., Yakunina N.Ya., Chudakova D.A., Nikitin A.G., Svetlova G.N., Soluyanova T.N., Strokov I.A., Nosikov V.V. 2007. The association of the TP53 polymorphisms Pro72Arg and C(−594)CC with diabetic polyneuropathy in Russian Muscovites with type 1 diabetes mellitus. Mol. Biol. 41, 989–993.

    Article  CAS  Google Scholar 

  7. Kastan M.B., Onyekwere O., Sidransky D., et al. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304–6311.

    PubMed  CAS  Google Scholar 

  8. Keim A.L., Chi M.M., Moley K.H. 2001. Hyperglycemia-induced apoptotic cell death in the mouse blastocystis dependent on expression of p53. Mol. Reprod. Dev. 60, 214–224.

    PubMed  Article  CAS  Google Scholar 

  9. Vincent A.M., Brownlee M., Russell J.W. 2002. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N.Y. Acad. Sci. 959, 368–383.

    PubMed  CAS  Article  Google Scholar 

  10. DiMauro S., Schon E.A. 2003. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 348, 2656–2668.

    PubMed  Article  CAS  Google Scholar 

  11. van Houten B., Woshner V., Santos J.H. 2006. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair. 5, 145–152.

    PubMed  Article  CAS  Google Scholar 

  12. Hudson G., Chinnery P.F. 2006. Mitochondrial DNA polymerase-gamma and human disease. Hum. Mol. Genet. 15, 244–252.

    Article  CAS  Google Scholar 

  13. Zheng W., Khrapko K., Coller H., et al. 2006. Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors. Mutat. Res. 599, 11–20.

    PubMed  CAS  Google Scholar 

  14. Graziewicz M.A., Longley M.J. Copeland W.C. 2006. DNA polymerase gamma in mitochondrial DNA replication and repair. Chem. Rev. 106, 383–405.

    PubMed  Article  CAS  Google Scholar 

  15. Lee W.S., Sokol R.J. 2007. Mitochondrial hepatopathies: Advances in genetics and pathogenesis. Hepatology. 45, 1555–1565.

    PubMed  Article  CAS  Google Scholar 

  16. Longley M.J., Ropp P.A., Lim S.E., et al. 1998. Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. Biochemistry. 37, 10529–10539.

    PubMed  Article  CAS  Google Scholar 

  17. Kaguni L.S. 2004. DNA polymerase gamma, the mitochondrial replicase. Annu. Rev. Biochem. 73, 293–320.

    PubMed  Article  CAS  Google Scholar 

  18. Longley M.J., Graziewicz M.A., Bienstock R.J., Copeland W.C. 2005. Consequences of mutations in human DNA polymerase gamma. Gene. 354, 125–131.

    PubMed  Article  CAS  Google Scholar 

  19. Luoma P.T., Eerola J., Ahola S., et al. 2007. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology. 69, 1152–1159.

    PubMed  Article  CAS  Google Scholar 

  20. Tiangyou W., Hudson G., Ghezzi D., et al. 2006. POLG1 in idiopathic Parkinson disease. Neurology. 67, 1698–1700.

    PubMed  Article  CAS  Google Scholar 

  21. Ferrari G., Lamantea E., Donati A., et al. 2005. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gamma A. Brain. 128, 723–731.

    PubMed  Article  Google Scholar 

  22. Nguyen K.V., Ostergaard E., Ravn S.H., et al. 2005. POLG mutations in Alpers syndrome. Neurology. 65, 1493–1495.

    PubMed  Article  CAS  Google Scholar 

  23. van Goethem G., Martin J.J., Dermaut B., et al. 2003. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromusc. Disord. 13, 133–142.

    PubMed  Article  Google Scholar 

  24. Korhonen J.A., Gaspari M., Falkenberg M. 2003. TWINKLE has DNA helicase activity and is specifically stimulated by mitochondrial single-stranded DNA-binding protein. J. Biol. Chem. 278, 48627–48632.

    PubMed  Article  CAS  Google Scholar 

  25. Korhonen J.A., Pham X.H., Pellegrini M., et al. 2004. Reconstitution of a minimal mtDNA replisome in vitro. EMBO J. 23, 2423–2429.

    PubMed  Article  CAS  Google Scholar 

  26. Spelbrink J.N., Toivonen J.M., Hakkaart G.A., et al. 2000. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J. Biol. Chem. 275, 24818–24828.

    PubMed  Article  CAS  Google Scholar 

  27. Tyynismaa H., Sembongi H., Bokori-Brown M., et al. 2004. Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. Hum. Mol. Genet. 13, 3219–3227.

    PubMed  Article  CAS  Google Scholar 

  28. Spelbrink J.N., Li F.-Y., Tiranti V., et al. 2001. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nature Genet. 28, 223–231.

    PubMed  Article  CAS  Google Scholar 

  29. Baloh R.H., Salavaggione E., Milbrandt J., et al. 2007. Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle. Arch. Neurol. 64, 998–1000.

    PubMed  Article  Google Scholar 

  30. Kristal B.S., Matsuda M., Yu B.P. 1996. Abnormalities in the mitochondrial permeability transition in diabetic rats. Biochem. Biophys. Res. Commun. 222, 519–523.

    PubMed  Article  CAS  Google Scholar 

  31. Halestrap A.P., McStay G.P., Clarke S.J. 2002. The permeability transition pore complex: Another view. Biochimie. 84, 153–166.

    PubMed  Article  CAS  Google Scholar 

  32. Vyssokikh M.Y., Brdiczka D. 2003. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim. Pol. 50, 389–404.

    PubMed  CAS  Google Scholar 

  33. Klingenberg M. 1985. The ADP/ATP carrier in mitochondrial membranes. In: The enzymes of Biological Membranes. N.Y.: Plenum Press, vol. 4, pp. 511–553.

    Google Scholar 

  34. Bottero V., Rossi F., Samson M., et al. 2001. Iκ b-α, the NF-κ B inhibitory subunit, interacts with ANT, the mitochondrial ATP/ADP translocator. J. Biol. Chem. 276, 21317–21324.

    PubMed  Article  CAS  Google Scholar 

  35. Belzacq A.S., Vieira H.L., Kroemer G., et al. 2002. The adenine nucleotide translocator in apoptosis. Biochimie. 84, 167–176.

    PubMed  Article  CAS  Google Scholar 

  36. Graham B.H., Waymire K.G., Cottrell B., et al. 1997. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genet. 16, 226–234.

    PubMed  Article  CAS  Google Scholar 

  37. Lodi T., Bove C., Fontanesi F., et al. 2006. Mutation D104G in ANT1 gene: Complementation study in Saccharomyces cerevisiae as a model system. Biochem. Biophys. Res. Commun. 341, 810–815.

    PubMed  Article  CAS  Google Scholar 

  38. Ziegler D., Hanefeld M., Ruhnau K.J., et al. 1995. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid: A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 38, 1425–1433.

    PubMed  Article  CAS  Google Scholar 

  39. Strokov I.A., Novosadova M.V., Barinov A.N., Yakhno N.N. 2000. Cliniocal methods for assessing the severity of diabetic polyneuropathy. Neurol. Zh. 5, 14–18.

    Google Scholar 

  40. Dyck P.J., Melton J.L., O’Brien P.C., Service F.G. 1997. Approaches to improve epidemiological studies of diabetic neuropathy: Insights from the Rochester Diabetic Neuropathy Study. Diabetes. 46, 5–8.

    Google Scholar 

  41. Komantsev V.N., Zabolotnykh V.A. 2001. Metodicheskie osnovy klinicheskoi elektroneiromiografii. Rukovodstvo dlya vrachei (Methodological Foundations of Clinical Electroneuromyography: A Manual for Doctors). St. Petersburg: Lan’.

    Google Scholar 

  42. Johns M.B., Paulus-Thomas J.E. 1989. Purification of human genomic DNA from whole blood using perchlorate in place of phenol. Anal. Biochem. 180, 276–278.

    PubMed  Article  CAS  Google Scholar 

  43. Hudson G., Chinnery P.F. 2006. Mitochondrial DNA polymerase-gamma and human disease. Hum. Mol. Genet. 15, 244–252.

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. State Research Center GosNIIgenetika, Moscow, 117545, Russia

    E. V. Spitsina, D. A. Chudakova, A. G. Nikitin & V. V. Nosikov

  2. Endocrinology Research Center, Moscow, 117036, Russia

    G. N. Svetlova & T. L. Kurayeva

  3. Sechenov Moscow Medical Academy, Moscow, 119992, Russia

    I. A. Strokov

Authors
  1. E. V. Spitsina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. N. Svetlova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. A. Chudakova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. G. Nikitin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. L. Kurayeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. A. Strokov
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. V. Nosikov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. V. Nosikov.

Additional information

Original Russian Text © E.V. Spitsina, G.N. Svetlova, D.A. Chudakova, A.G. Nikitin, T.L. Kurayeva, I.A. Strokov, V.V. Nosikov, 2009, published in Molekulyarnaya Biologiya, 2009, Vol. 43, No. 2, pp. 378–382.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Spitsina, E.V., Svetlova, G.N., Chudakova, D.A. et al. Association of the POLG1 T(−365)C, ANT1 G(−25)A, and PEO1 G(−605)T polymorphisms with diabetic polyneuropathy in patients with Type 1 diabetes mellitus. Mol Biol 43, 348–352 (2009). https://doi.org/10.1134/S0026893309020186

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893309020186

Key words

  • diabetic polyneuropathy
  • POLG1
  • ANT1
  • PEO1
  • association
  • polymorphic markers